FdaApplication

NDA 020234

Back to search

Identifiers

Properties

PropertyValue
applicant_nameNOVARTIS PHARMACEUTICALS CORP
application_typeNDA
approval_date1996-03-25

Products (3)

ProductActive ingredientStrengthDosage form
TEGRETOL-XRCARBAMAZEPINE100MGTABLET, EXTENDED RELEASE;ORAL
TEGRETOL-XRCARBAMAZEPINE200MGTABLET, EXTENDED RELEASE;ORAL
TEGRETOL-XRCARBAMAZEPINE400MGTABLET, EXTENDED RELEASE;ORAL

3 products